Introduction
============

Many studies have found associations between fine particulate matter \[PM with aerodynamic diameter ≤ 2.5 μm (PM~2.5~)\] and increased mortality ([@r12]; [@r15]; [@r34]; [@r39]; [@r55]). Biological evidence has been established for plausible mechanisms between PM~2.5~ and mortality, such as increased risk of ventricular arrhythmia and thrombotic processes, increased system inflammation and oxidative stress, increased blood pressure, decreased plaque stability, and reduced lung function, among others ([@r4]; [@r17]; [@r18]; [@r47]; [@r54]). Based on evidence from epidemiological and toxicological studies ([@r6]; [@r16]; [@r32]), National Ambient Air Quality Standards (NAAQS) were implemented for fine particulate matter. For example, the U.S. Environmental Protection Agency (EPA) revised the fine particle NAAQS in 1997, 2006, and 2012 in order to protect public health ([@r50], [@r51], [@r52]). Further changes in the standards require additional studies to elucidate whether health effects occur at levels below the current annual and daily U.S. EPA NAAQS of 12 and 35 μg/m^3^, respectively. The [@r7] require the U.S. EPA to review national air quality standards every 5 years to determine whether they should be retained or revised; thus, whether health effects can be observed below the current standards is of great interest and importance.

Previous studies have generally focused on either long-term ([@r19]; [@r21]; [@r36]; [@r40]) or short-term ([@r13]; [@r22]; [@r38]; [@r43]) exposures across the entire range of PM~2.5~ concentrations. In the case of time series analyses of short-term exposures, the need to ensure the relevance of the monitoring data as well as the need to have a study population of a size for sufficent power has limited analyses to large cities; hence, exurbs, small cities, and rural areas are not generally represented in the literature, which may compromise the generalizability of the results. In addition, there is spatial variability in PM~2.5~ concentrations within cities that time series studies generally do not take into account, which can introduce exposure measurement error ([@r28]; [@r30]).

Chronic effects studies began using comparisons across cities of mortality experiences of cohorts living in various communities and the monitored air pollutant concentrations in those communities ([@r12]; [@r35]). Again, these studies suffered from exposure error due to failure to capture within-city spatial variability in exposure. Because the geographic exposure gradient is the exposure contrast in these studies, the failure to capture within-city contrasts leads to classical measurement error with expected downward bias. Studies with, for example, land use regression estimates of exposure have generally reported larger effect sizes ([@r31]; [@r36]). Previous cohort studies have not controlled for the acute effects of particles when estimating chronic effects, raising the question of whether there are independent chronic effects that represent more than the cumulative effects of acute responses.

In general, existing study cohorts are not representative of the overall population. For example, the American Cancer Society (ACS) cohort has a higher level of education than the U.S. population as a whole ([@r46]). Hence, few population-based cohort studies have been conducted until recently ([@r27]).

Several time series studies examined the concentration--response relationship between PM~2.5~ and mortality below concentrations of 100 μg/m^3^; these studies generally reported a linear concentration--response relationship ([@r38]; [@r45]). However, there have been few studies focusing on exposures below the current daily U.S. EPA standard of 35 μg/m^3^.

Many studies have examined the shape of the concentration--response curve for long-term exposure versus short-term exposure, but in general, they have not covered population-based cohorts, or have only included very low exposures ([@r42]; [@r11]).

We recently presented a new hybrid method of assessing temporally and spatially resolved PM~2.5~ exposure for epidemiological studies by combining 1 km × 1 km resolution satellite-retrieved aerosol optical depth (AOD) measurements with traditional land use terms, meteorological variables, and their interactions ([@r23]). This approach allows for predicting daily PM~2.5~ concentrations at a 1 km × 1 km spatial resolution throughout the New England area of the northeastern United States. We also validated our model's performance in rural areas: 10-fold cross-validation (CV) of our model in rural areas (using the IMPROVE stations) resulted in a CV *R*^2^ of 0.92. Further details have been published ([@r23]).

The present study aimed to simultaneously estimate acute and chronic health effects of PM~2.5~ in a population-based Medicare cohort (≥ 65 years of age) encompassing the New England region. We used high-spatial-resolution exposure estimates based on satellite measurements that are available across the region and not just in limited locations. To make this study relevant to future assessments of current U.S. EPA standards, we repeated the analysis after restricting the data to long-term exposures (365-day moving average) \< 10 μg/m^3^ and repeated the time series analysis of short-term exposures after restricting the data to 2-day average exposures \< 30 μg/m^3^.

Methods
=======

*Study domain.* The spatial domain of our study included the New England area, comprising the states of Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, and Vermont ([Figure 1A](#f1){ref-type="fig"}).

![(*A*) Mean PM~2.5~ concentrations in 2004 at a high resolution (1 km × 1 km) across New England predicted by the AOD models. (*B*) Predicted PM~2.5~ concentrations at a 1 km × 1 km grid for 15 November 2003.](ehp.1409111.g001){#f1}

*Exposure data.* A 3-stage statistical modeling approach for predicting daily PM~2.5~ was previously reported incorporating AOD and land use data for the New England region ([@r25]). Previous studies have shown that using actual physical measurements in our prediction models improved predictive accuracy over that of comparable land use or spatial smoothing models ([@r25]). With AOD retrieved by the multi-angle implementation of atmospheric correction (MAIAC) algorithm, a similar approach was applied for estimating daily PM~2.5~ exposures in New England at a spatial resolution of 1 km × 1 km ([@r23]). In this study, the same PM~2.5~ exposure predictions were employed.

Briefly, we calibrated the AOD--PM~2.5~ relationship on each day of the study period (2003--2008) using data from grid cells with both ground PM~2.5~ monitors and AOD measurements (stage 1), and we used inverse probability weighting to address selection bias due to nonrandom missingness patterns in the AOD measurements. We then used the AOD--PM~2.5~ relationship to predict PM~2.5~ concentrations for grid cells that lacked monitors but had available AOD measurement data (stage 2). Finally, we used a generalized additive mixed model (GAMM) with spatial smoothing and a random intercept for each 1 km × 1 km grid cell to impute data for grid cells/days for which AOD measurements were not available (stage 3). The performance of the estimated PM~2.5~ was validated by 10-fold cross-validation. High out-of-sample *R*^2^ (*R*^2^ = 0.89, year-to-year variation 0.88--0.90 for the years 2003--2008) was found for days with available AOD data. Excellent performance held even in cells/days with no available AOD (*R*^2^ = 0.89, year-to-year variation 0.87--0.91 for the years 2003--2008). The 1-km model had better spatial (0.87) and temporal (0.87) out-of-sample *R*^2^ than the previous 10-km model (0.78 and 0.84, respectively). Details of the PM~2.5~ prediction models are in [@r23].

[Figure 1A](#f1){ref-type="fig"} shows an example of mean PM~2.5~ concentrations in 2004 at a 1 km × 1 km spatial resolution across New England. By averaging the estimated daily exposures at each location, we generated long-term exposures.

[Figure 1B](#f1){ref-type="fig"} (a subset of the study area) shows that spatial variability existed even for daily data and was not identical to the long-term pattern shown in [Figure 1A](#f1){ref-type="fig"}. That is, there was space--time variation in the PM~2.5~ exposure captured in this analysis, but not in previous time-series analyses.

Because the deaths were coded at the ZIP code level, both long- and short-term predictions were matched to ZIP codes by using ArcGIS (ESRI, Redlands, CA) and SAS (SAS Institute Inc., Cary, NC) to link the ZIP code centroid to the nearest PM~2.5~ grid.

Traditionally, studies of acute air pollution effects have controlled for temperature using values taken from the nearest airport. This approach is not feasible for the entire region because many residences are distant from airports. In addition, there is spatiotemporal variation in temperature. We have applied a similar 3-stage statistical modeling approach to estimate daily ambient temperature at 1 km × 1 km resolution in New England using satellite-derived surface temperature ([@r26]). To our knowledge, such fine control for temperature has not previously been used in air pollution epidemiology.

*Mortality data.* Individual mortality records were obtained from the U.S. Medicare program for all residents ≥ 65 years of age for all available years during 2003--2008 ([@r9]). The Medicare cohort was used because of the availability of ZIP code of residence data, whereas National Center for Health Statistics mortality data are only available at the county level. Additionally, previous studies found that elderly people are highly susceptible to the effects of particulate matter ([@r33]). The Medicare beneficiary denominator file from the Centers for Medicare and Medicaid services ([@r8]) lists all beneficiaries enrolled in the Medicare fee-for-service (FFS) program and contains information on beneficiaries' eligibility and enrollment in Medicare and the date of death. The Medicare Provider Analysis and Review (MEDPAR) file includes information on age, sex, race, ZIP code of residence, and one record for each hospital admission ([@r10]).

Daily mortality was first aggregated by ZIP code and then matched with the corresponding PM~2.5~ exposure. We summarized the mortality data by ZIP code and day because that was the finest resolution we could obtain for addresses. Because the mortality data sets did not include changes of residence, we assumed that the subjects lived at their current address over the entire study period.

*Covariates.* We used daily 1-km temperature data estimated from surface temperature measured by satellites ([@r26]). All socioeconomic variables were obtained through the [@r48] Census Summary File 3, which includes social, economic, and housing characteristics ([@r48]). ZIP code tabulation area--level socioeconomic variables, including race, education, and median household income, were used. The county-level percentage of people who currently smoke every day, obtained from the CDC Behavioral Risk Factor Surveillance survey for the entire country, was also adjusted ([@r5]). Dummy variables were used to control for day of the week.

*Statistical models.* Conventionally, the acute effects of air pollution are estimated by Poisson log-linear models, and the chronic effects of air pollution are estimated by Cox proportional hazard models ([@r27]; [@r28]). [@r29] noted the equivalence of the likelihood of a proportional hazard model with piecewise constant hazard for each year of follow-up and a Poisson regression with a dummy variable for each year of follow-up. We have taken advantage of this equivalence to generalize from dummy variables for each year to a spline of time to represent the baseline hazard and to aggregate subjects into counts per person time at risk, and we obtained a mixed Poisson regression model ([@r24]). This approach allows the rate of death as a function of both long- and short-term exposures to be modeled simultaneously. By doing so, we achieved the equivalence of a separate time series analysis for each ZIP code, greatly reducing the exposure error in that part of the model, while simultaneously conducting a survival analysis on the participants, and we were also able to estimate the independent effects of both exposures.

Most time series studies have reported stronger associations with acute exposures when exposures were defined as the mean PM~2.5~ on the day of death and the previous day (lag01) than when they were defined as the mean PM~2.5~ on the current day only, or for exposures with longer lags ([@r44]; [@r41]). We used the lag01 average for our main analysis but performed a sensitivity analysis on that choice. Long-term exposure was calculated as the 365-day moving average ending on the date of death so that our results were comparable with those of previous studies ([@r30]; [@r42]). Short-term exposure was defined as the difference between the 2-day average and the long-term average, ensuring that acute and chronic effects were independent. We subtracted the long-term average from the short-term average to avoid collinearity issues and to ensure that differences between ZIP codes in PM~2.5~ at a given time did not contribute to the short-term effect estimate. Thus, the short-term effect could not be confounded by variables that differed across ZIP codes.

Specifically, we fit a Poisson survival analysis with a logarithmic link function and a log (population) offset term and modeled the expected daily death counts (μ*~it~*) in the *i*th ZIP code on the *t*th day as follows:

log(*μ~it~*) = λ*~i~* + β~1~*PM~it~* + β~2~Δ*PM~it~* + λ(*t*) + temporal covariates + spatial covariates + offset, \[1\]

where λ*~i~* is a random intercept for each ZIP code, *PM~it~* is the 365-day moving average ending on day *t* in ZIP code *i*, Δ*PM~it~* is the deviation of the 2-day average from its long-term average (*PM~it~*) in ZIP code *i*, λ(*t*) is a smooth function of time, temporal covariates are temperature and day of the week, and spatial covariates are socioeconomic factors defined at the ZIP code level (percent of people without high school education, percent of white people, median household income) and smoking data at the county level. Additionally, a quasi-Poisson model was used to control for possible overdispersion ([@r52]).

We estimated λ(*t*) with a natural cubic spline with 5 degrees of freedom (df) per year to control for time and season trends. The specific temporal and spatial covariates that we used were a natural cubic spline for temperature with 3 df in total; a categorical variable for day of the week; linear variables for percent of people without high school education, percent of white people, median household income, and percent of people who currently smoke every day.

The number of deaths per ZIP code area over the study period (2003--2008) averaged 319 with a standard deviation of 430. Because the outcome was counts, we could not adjust for age and sex as in a Cox model. Instead, we adjusted for variables that varied by ZIP code. The analyses were repeated without mutual adjustment for short- and long-term PM~2.5~.

We modeled the association between all-cause mortality and PM~2.5~ at low doses in which the person-time at risk in each year of follow-up in each ZIP code was used as the offset. We also conducted effect modification by population size by choosing the median (4,628) of the ZIP code--level total population as the cutoff between urban and rural areas.

*Estimating the effects of low-level PM~2.5~.* For full cohort analyses with 10,938,852 person-years of follow-up, all observed deaths were used. To estimate effects at low levels of exposure, we performed restricted analyses: we conducted one analysis restricted to annual exposures \< 10 μg/m^3^, below the current annual PM~2.5~ NAAQS of 12 μg/m^3^, and another restricted to observations with short-term exposure \< 30 μg/m^3^, below the current daily PM~2.5~ NAAQS of 35 μg/m^3^. After these exclusions, the chronic analyses were restricted to 268,050 deaths out of 551,024 deaths in total, and the acute analyses were restricted to 422,637 deaths.

*Assessing the dose--response relationship.* For both the acute and chronic analyses, we fit penalized regression splines in the restricted analyses to estimate the shape of the dose--response curve below current U.S. EPA standards. The degrees of freedom of the penalized splines for PM~2.5~ were estimated by generalized cross-validation (GCV).

Results
=======

[Table 1](#t1){ref-type="table"} presents a summary of the predicted exposures for both short- and long-term PM~2.5~ exposure across all grid cells in the study area.

###### 

Descriptive statistics for PM~2.5~ exposure and temperature in New England, 2003--2008.

  Covariate                 Mean   SD     Minimum   Median   Maximum   Range   Q1     Q3      IQR
  ------------------------- ------ ------ --------- -------- --------- ------- ------ ------- ------
  Lag01 PM~2.5~(μg/m^3^)    8.21   5.10   0.00      7.10     53.98     53.98   4.60   10.65   6.05
  1-year PM~2.5~(μg/m^3^)   8.12   2.28   0.08      8.15     20.22     20.14   6.22   10.00   3.78
  Temperature (˚C)          9.24   6.50   --36.79   9.81     41.51     78.30   4.90   14.39   9.49

[Table 2](#t2){ref-type="table"} presents the estimated percent change in all-cause mortality with 95% CIs for a 10-μg/m^3^ increase in both short- and long-term PM~2.5~ in the restricted and full cohort. In the restricted population, we found an estimated 9.28% increase in mortality (95% CI: 0.76, 18.52%) for every 10-μg/m^3^ increase in long-term PM~2.5~ exposure. A 2.14% increase in mortality (95% CI: 1.34, 2.95%) was observed for every 10-μg/m^3^ increase in short-term PM~2.5~ exposure. For long-term exposure, the effect estimates were smaller when higher pollution days were included (7.52%; 95% CI: 1.95, 13.40%), suggesting larger effects between low-concentration long-term PM~2.5~ and mortality.

###### 

Percent increase in mortality (95% CI) for a 10-μg/m^3^ increase for both short-term and long-term PM~2.5~.

  PM~2.5~ exposure                                                                                                                                                                                                                                                         Model                       Percent increase   *p*-Value
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ --------------------------- ------------------ -----------
  With mutual adjustment                                                                                                                                                                                                                                                                                                  
  Short-term PM~2.5~                                                                                                                                                                                                                                                       Low daily exposure^*a*^     2.14 ± 0.81        \< 0.001
  Full cohort                                                                                                                                                                                                                                                              2.14 ± 0.75                 \< 0.001           
  Long-term PM~2.5~                                                                                                                                                                                                                                                        Low chronic exposure^*b*^   9.28 ± 8.88        0.032
  Full cohort                                                                                                                                                                                                                                                              7.52 ± 5.73                 0.007              
  Without mutual adjustment                                                                                                                                                                                                                                                                                               
  Short-term PM~2.5~                                                                                                                                                                                                                                                       Low daily exposure^*a*^     2.07 ± 0.80        \< 0.001
  Full cohort                                                                                                                                                                                                                                                              2.08 ± 0.76                 \< 0.001           
  Long-term PM~2.5~                                                                                                                                                                                                                                                        Low chronic exposure^*b*^   7.16 ± 8.75        0.109
  Full cohort                                                                                                                                                                                                                                                              6.46 ± 5.69                 0.026              
  The full cohort analysis had 551,024 deaths. ^***a***^The analysis was restricted only to person time with daily PM~2.5~ \< 30 μg/m^3^ (422,637 deaths). ^***b***^The analysis was restricted only to person time with chronic PM~2.5~ \< 10 μg/m^3^ (268,050 deaths).                                                  

Without mutual adjustment, lower estimates were found for both acute and chronic effects than for those with mutual adjustment. In full-cohort analyses, a 2.08% (95% CI: 1.32, 2.84%) and a 6.46% (95% CI: 0.93, 12.30%) increase in mortality was found for each 10-μg/m^3^ increase in short- and long-term PM~2.5~, respectively. In restricted analyses, the corresponding effect estimates were 2.07% (95% CI: 1.27, 2.89%) and 7.16% (95% CI: --1.23, 16.27%), respectively.

Our results were robust to the choice of lag period for acute exposure. We analyzed different averaging periods ([Figure 2](#f2){ref-type="fig"}): for example, lag0 (day of death exposure) and lag04 (a moving average of day of death exposure and previous 4-day exposure). For the acute effects, we found a significant but smaller association for lag0 PM~2.5~ (1.71%; 95% CI: 1.09, 2.34%) and lag04 PM~2.5~ (1.76%; 95% CI: 0.72, 2.81%) than for lag01 analysis. The lag period used for short-term exposure did not affect estimates of chronic effects. For example, estimated increases in mortality with a 10-μg/m^3^ increase in long-term PM~2.5~ were 7.35% (95% CI: 1.79, 13.21%) and 7.25% (95% CI: 1.69, 13.12%) when short-term PM~2.5~ was classified using lag0 or lag04, respectively.

![Percent change in mortality per 10-μg/m^3^ increase in short-term PM~2.5~ with different lags with mutual adjustment. Error bars indicate the 95% CIs.](ehp.1409111.g002){#f2}

We also examined effect modification by population size. In the full cohort, a significant interaction was found for chronic effects (*p* \< 0.01), with a larger effect of 12.56% (95% CI: 5.71, 19.85%) in urban areas compared with 3.21% (95% CI: --2.92, 9.72%) in rural areas. Such a significant interaction, however, was not observed in the restricted analysis (*p* = 0.16). Estimates were 14.27% (95% CI: 3.19, 26.53%) and 5.48% (95% CI: --4.21, 16.16%) in urban and rural areas, respectively. For short-term exposure, population size did not modify the acute effects in either the full cohort or the restricted analysis (*p* = 0.74 and 0.46, respectively).

In our penalized spline model for long-term exposure below the cutoff of 10 μg/m^3^ ([Figure 3A](#f3){ref-type="fig"}), we found a nonlinear relationship between long-term PM~2.5~ and mortality. The association was linear with evidence of a smaller effect \< 6 μg/m^3^. However, a large confidence interval was observed; hence, we could not be confident whether the slope of the dose--response curve changed for long-term exposures \< 6 μg/m^3^. When examining the shape of the dose--response curve for chronic effects, both a linear term for short-term exposure (the difference) and a penalized spline for long-term average exposure were included in the model, resulting in a penalized spline with a df of 1.71. In contrast, we only included the 2-day average in the penalized spline model of acute effects in order to provide an interpretable dose--response relationship ([Figure 3B](#f3){ref-type="fig"}). The results of this analysis indicated a linear association across the exposure distribution, but we could not be certain about the shape of the slope for acute effects \< 3 μg/m^3^.

![The dose--response relationship between long-term PM~2.5~ and mortality at low doses with mutual adjustment (*A*) and the dose--response relationship between short-term PM~2.5~ and mortality at low doses without mutual adjustment (*B*). Shaded areas indicate the 95% CIs.](ehp.1409111.g003){#f3}

Discussion
==========

When we applied the predicted daily PM~2.5~ with 1-km spatial resolution from our novel hybrid models, we observed that both short- and long-term PM~2.5~ exposure were significantly associated with all-cause mortality among residents of New England ≥ 65 years of age, even when restricted to ZIP codes and times with annual exposures \< 10 μg/m^3^ or with daily exposure \< 30 μg/m^3^. Hence, the association of particle exposure with mortality exists for concentrations below the current standards established by the United States, the World Health Organization (WHO) (10 μg/m^3^ of annual average PM~2.5~, 25 μg/m^3^ daily), and the European Union (EU) (25 μg/m^3^ of annual average PM~2.5~) ([@r14]; [@r53]). Notably, this analysis includes all areas in New England and all Medicare enrollees ≥ 65 years of age in this region, and it provides chronic effect estimates that are independent of acute effects. Based on a penalized spline model, the positive dose--response relationship between chronic exposure and mortality appears to be linear for PM~2.5~ concentrations ≥ 6 μg/m^3^, with a positive (though smaller and less precise) dose--response slope continuing below this level. This lack of power is likely due to the small exposed population in areas with annual PM~2.5~ \< 6 μg/m^3^, which were quite rural.

For acute effects, we found a 2.14% (95% CI: 1.38, 2.89%) increase in all-cause mortality per 10-μg/m^3^ increment in PM~2.5~ for the full cohort of our study, which is higher than the effect size of most studies using city averages obtained from monitors. For instance, in a U.S. national study by [@r55], the effect size was 0.98% (95% CI: 0.75, 1.22%). Similar results were also obtained in a systematic review, where researchers determined that the overall summary estimate was 1.04% (95% CI: 0.52, 1.56%) per 10-μg/m^3^ increment in PM~2.5~ ([@r1]). The exposure data used in most previous studies had low spatial resolution (citywide average, not ZIP code), which introduced exposure measurement error and likely resulted in a downward bias in estimates; our results (for the acute effect) are consistent with such a phenomenon. Our restricted study estimated a 2.14% (95% CI: 1.34, 2.95%) increase in all-cause mortality per 10-μg/m^3^ increment in PM~2.5~, which was close to the effect size of the full cohort study, possibly because the sample size of the restricted study for acute effects was close to that of the full cohort. Furthermore, the U.S. EPA daily standard (35 μg/m^3^) was almost never exceeded in this study. In addition, lower effect estimates for short-term exposure were observed with mutual adjustment for both full cohort and restricted analyses. This finding has important implications for the interpretation of previous studies without such mutual adjustment.

For chronic effects, the effect estimate in our full cohort study was consistent with findings of previous studies with comparable sample sizes ([@r20]; [@r28]; [@r30]). For example, an ACS study comprising 500,000 adults from 51 U.S. cities reported a 6% (95% CI: 2, 11%) increase in all-cause mortality for each 10-μg/m^3^ increment in PM~2.5~ ([@r34]). A study of 13.2 million elderly Medicare recipients across the eastern United States found a 6.8% (95% CI: 4.9, 8.7%) increase in all-cause mortality for each 10-μg/m^3^ increment in PM~2.5~ ([@r56]). When we restricted our analysis to annual concentrations \< 10 μg/m^3^, a larger slope of 9.28% (95% CI: 0.76, 18.52%) increase per 10 μg/m^3^ was observed. Our findings suggest a larger effect at low concentrations among those ≥ 65 years of age, which may also reflect particle composition. The sources and composition of the particles may differ between low-pollution days and high-pollution days, which are likely more affected by secondary aerosols. Compared with the effect estimate for the full cohort, the effect estimate from the restricted analysis was closer to estimates published in the literature that reported larger effect estimates, such as those reported by the ESCAPE (European Study of Cohorts for Air Pollution Effects) study, the Harvard Six Cities study, and the Women's Health Initiative study ([@r2]; [@r37]). Smaller effect estimates were also observed for chronic effects without mutual adjustment.

To the best of our knowledge, this study is the first of its kind to restrict exposure and to explore the dose--response relationship between PM~2.5~ below the current U.S. EPA standards (12 μg/m^3^ of annual average PM~2.5~, 35 μg/m^3^ daily) and mortality. Moreover, the use of the Medicare cohort means that we studied the entire population of Medicare enrollees ≥ 65 years of age and not a convenience sample. In addition, temperature was controlled on a 1 km × 1 km fine geographic scale. The acute and chronic effects observed in analyses restricted to low PM~2.5~ exposure were similar to or even higher than those of the full cohort analyses. These results indicate that the adverse health effects of PM~2.5~ are at least retained, if not strengthened, at low levels of exposure. However, the findings from the penalized spline model did not support a strong association at the lowest range of PM~2.5~ concentrations. This finding provides epidemiological evidence for the reevaluation of U.S. EPA guidelines and standards, although more evidence is needed to confirm the association \< 6 μg/m^3^.

The Poisson survival analysis applied in this study provided a novel method of simultaneously assessing acute and chronic effects. As shown in our analysis, the chronic effect estimate was much larger than the acute effect estimate after controlling for the acute estimate, indicating that there were chronic effects of PM~2.5~, which cannot be solely explained by the short-term exposure.

Another key component of this study is that the application of high spatial (1 km × 1 km) and temporal (daily) resolution of PM~2.5~ concentrations reduced exposure error to a certain extent. The out-of-sample *R*^2^ was higher than that for the predictions with 10 km × 10 km spatial resolution.

A potential limitation is the limited availability of individual-level confounders, such as smoking status, which could bias the health effect estimates. We were able to control for ZIP code--level education, median income, race, and county-level smoking data. However, [@r3] reported that census tract--level socioeconomic indicators were uncorrelated with PM~2.5~ on the subregional and local scale, providing some assurance that confounding by socioeconomic status may not be much of an issue. The results reported by [@r3] suggest that those variables may not confound the association, but the inability to control for them remains an issue. Another limitation is that we did not examine other pollutants such as ozone (O~3~) or nitrogen dioxide (NO~2~) owing to a lack of data at the same spatial level as that of PM~2.5~.

Conclusions
===========

In conclusion, the acute and chronic effects of low-concentration PM~2.5~ were examined for a Medicare population using a comprehensive exposure data set obtained from a satellite-based prediction model. Our findings show that both short- and long-term exposure to PM~2.5~ were associated with all-cause mortality, even for exposure levels not exceeding the newly revised U.S. EPA standards, suggesting that adverse health effects occur at low levels of fine particles. The policy implication of these findings is that improving the air quality at even lower levels of PM~2.5~ than presently allowed by the U.S. EPA standards can yield health benefits.
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